NCT05881317View on ClinicalTrials.gov

ArtiAid® Plus for Knee Osteoarthritis: A Post-market Study

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

June 6, 2022

Study Completion Date

November 21, 2022

Conditions
Hyaluronic Acid
Interventions
DEVICE

ArtiAid® Plus Intra-articular Injection

Inject ArtiAid® Plus in the affected joint at weekly interval for 3 weeks

Trial Locations (1)

33383

Maxigen Biotech Inc., Taoyuan

Sponsors
All Listed Sponsors
lead

Maxigen Biotech Inc.

INDUSTRY

NCT05881317 - ArtiAid® Plus for Knee Osteoarthritis: A Post-market Study | Biotech Hunter | Biotech Hunter